SupplierRadar
Sign inStart free

Glaxosmithkline Colombia S.A

FDA import alert and refusal historyBogota, ColombiaFEI 3004011984

Watch this supplier

Watch this supplier

Get an email when FDA publishes anything new on Glaxosmithkline Colombia S.A.

Enter your work email and confirm with the link we send. Your first supplier is free, with no password and no card.

Example subjectGlaxosmithkline Colombia S. added to Import Alert 16-129 (red list)

Free for one supplier. No password, no card.

As of October 26, 2026, Glaxosmithkline Colombia S.A is not on any FDA import alert in SupplierRadar's records; FDA refused 5 of its shipment lines between April 25, 2019 and January 5, 2022, most often for required label information not in english (NO ENGLISH).

Data from FDA public records, last checked . Request a correction

Current status

Import alerts
Not listed
Last import refusal
Soft drinks and waters not mentioned elsewhere, n.e.c. · NO ENGLISH
Last warning letter
None found
Last inspection
None on record

Every FDA record for Glaxosmithkline Colombia S.A

5 records, newest first. Each line links to the FDA page it came from.

2022

  1. Import refusal
    Refused, Soft drinks and waters not mentioned elsewhere, n.e.c.NO ENGLISHDIETARYINGEntry AMN-0067767-0
    Source

2019

  1. Import refusal
    Refused, 4 lines in one entry: Fish oil (fats and lipid substances)NO ENGLISHEntry B4Y-0009981-4Show 4 lines
    Source

Refusal charges, in plain English

  • NO ENGLISH5 refused lines

    Required label information not in English

    Information that must appear on the label appeared not to be given in English, or not to be repeated in every language used on the label.

  • DIETARYING1 refused line

    Dietary ingredients not listed

    The dietary supplement label appeared not to list each dietary ingredient and its quantity, or the total quantity of a proprietary blend.

Questions about Glaxosmithkline Colombia S.A

Is Glaxosmithkline Colombia S.A on an FDA import alert?
No listing for Glaxosmithkline Colombia S.A appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the Colombia page.
Has FDA refused shipments from Glaxosmithkline Colombia S.A?
Yes. FDA refused 5 shipment lines from Glaxosmithkline Colombia S.A between April 25, 2019 and January 5, 2022. The most recent, on January 5, 2022, was soft drinks and waters not mentioned elsewhere, n.e.c., charged as NO ENGLISH (required label information not in english).
Why did FDA refuse Glaxosmithkline Colombia S.A's shipments?
The most frequent charges are NO ENGLISH (required label information not in english, 5 lines) and DIETARYING (dietary ingredients not listed, 1 line).
What is Glaxosmithkline Colombia S.A's FEI number?
Glaxosmithkline Colombia S.A's FDA Establishment Identifier (FEI) is 3004011984.

Buying from Glaxosmithkline Colombia S.A?

Watch it and get the FDA record the day it changes. Free for one supplier.

Watch this supplier

Watch this supplier

Get an email when FDA publishes anything new on Glaxosmithkline Colombia S.A.

Enter your work email and confirm with the link we send. Your first supplier is free, with no password and no card.

Example subjectGlaxosmithkline Colombia S. added to Import Alert 16-129 (red list)

Free for one supplier. No password, no card.

SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.